Quantitative Measurement of the Affinity of Toxic and Nontoxic Misfolded Protein Oligomers for Lipid Bilayers and of its Modulation by Lipid Composition and Trodusquemine.
Alzheimer’s disease
Parkinson’s disease
aminosterols
neurodegeneration
protein misfolding
squalamine
Journal
ACS chemical neuroscience
ISSN: 1948-7193
Titre abrégé: ACS Chem Neurosci
Pays: United States
ID NLM: 101525337
Informations de publication
Date de publication:
01 09 2021
01 09 2021
Historique:
pubmed:
13
8
2021
medline:
4
9
2021
entrez:
12
8
2021
Statut:
ppublish
Résumé
Many neurodegenerative diseases are associated with the self-assembly of peptides and proteins into fibrillar aggregates. Soluble misfolded oligomers formed during the aggregation process, or released by mature fibrils, play a relevant role in neurodegenerative processes through their interactions with neuronal membranes. However, the determinants of the cytotoxicity of these oligomers are still unclear. Here we used liposomes and toxic and nontoxic oligomers formed by the same protein to measure quantitatively the affinity of the two oligomeric species for lipid membranes. To this aim, we quantified the perturbation to the lipid membranes caused by the two oligomers by using the fluorescence quenching of two probes embedded in the polar and apolar regions of the lipid membranes and a well-defined protein-oligomer binding assay using fluorescently labeled oligomers to determine the Stern-Volmer and dissociation constants, respectively. With both approaches, we found that the toxic oligomers have a membrane affinity 20-25 times higher than that of nontoxic oligomers. Circular dichroism, intrinsic fluorescence, and FRET indicated that neither oligomer type changes its structure upon membrane interaction. Using liposomes enriched with trodusquemine, a potential small molecule drug known to penetrate lipid membranes and make them refractory to toxic oligomers, we found that the membrane affinity of the oligomers was remarkably lower. At protective concentrations of the small molecule, the binding of the oligomers to the lipid membranes was fully prevented. Furthermore, the affinity of the toxic oligomers for the lipid membranes was found to increase and slightly decrease with GM1 ganglioside and cholesterol content, respectively, indicating that physicochemical properties of lipid membranes modulate their affinity for misfolded oligomeric species.
Identifiants
pubmed: 34382791
doi: 10.1021/acschemneuro.1c00327
pmc: PMC8414483
doi:
Substances chimiques
3-N-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate
0
Amyloid beta-Peptides
0
Cholestanes
0
Lipid Bilayers
0
Spermine
2FZ7Y3VOQX
G(M1) Ganglioside
37758-47-7
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
3189-3202Références
Sci Rep. 2020 Oct 20;10(1):17733
pubmed: 33082392
Biochim Biophys Acta. 2007 Aug;1768(8):1943-51
pubmed: 17321494
Annu Rev Biochem. 2017 Jun 20;86:27-68
pubmed: 28498720
Biochim Biophys Acta. 2013 Dec;1832(12):2302-14
pubmed: 24075940
Int J Mol Sci. 2018 Aug 18;19(8):
pubmed: 30126198
ACS Chem Neurosci. 2019 Aug 21;10(8):3464-3478
pubmed: 31313906
Cell. 2012 May 25;149(5):1048-59
pubmed: 22632969
Proc Natl Acad Sci U S A. 2011 Dec 27;108(52):21057-62
pubmed: 22160682
Biophys J. 2017 Nov 21;113(10):2271-2280
pubmed: 29113676
Protein Sci. 2001 Apr;10(4):879-86
pubmed: 11274479
J Neurochem. 1995 Jan;64(1):424-9
pubmed: 7798942
Biochemistry. 1998 Jun 2;37(22):8180-90
pubmed: 9609714
Commun Biol. 2020 Aug 13;3(1):435
pubmed: 32792544
Chem Commun (Camb). 2018 Aug 11;54(62):8637-8640
pubmed: 30020284
Nanoscale. 2019 Nov 21;11(43):20857-20867
pubmed: 31657431
Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12479-84
pubmed: 22802614
Langmuir. 2014 Nov 25;30(46):13934-41
pubmed: 25360827
Nanoscale. 2020 Oct 14;12(38):19746-19759
pubmed: 32966489
J Am Chem Soc. 2014 Oct 15;136(41):14554-9
pubmed: 25229711
J Mol Biol. 2002 Aug 30;321(5):785-96
pubmed: 12206761
ACS Chem Biol. 2018 Aug 17;13(8):2308-2319
pubmed: 29953201
J Alzheimers Dis. 2013;33 Suppl 1:S67-78
pubmed: 22531422
J Cell Sci. 2016 May 1;129(9):1792-801
pubmed: 26989132
Biochim Biophys Acta. 2016 Feb;1858(2):386-92
pubmed: 26656159
Nat Commun. 2021 Mar 22;12(1):1814
pubmed: 33753734
Methods Mol Biol. 2021;2187:47-86
pubmed: 32770501
J Cell Mol Med. 2011 Oct;15(10):2106-16
pubmed: 21155974
ACS Chem Neurosci. 2021 Feb 17;12(4):766-781
pubmed: 33538575
J Alzheimers Dis. 2011;24 Suppl 2:223-32
pubmed: 21460436
Biochim Biophys Acta Gen Subj. 2018 Jun;1862(6):1432-1442
pubmed: 29571746
J Mol Biol. 2007 Apr 13;367(5):1237-45
pubmed: 17320902
Biochim Biophys Acta. 2015 Sep;1848(9):1897-907
pubmed: 25666871
Nanoscale. 2020 Nov 19;12(44):22596-22614
pubmed: 33150350
Biochim Biophys Acta. 2014 Sep;1842(9):1622-9
pubmed: 24932517
Nat Struct Mol Biol. 2020 Dec;27(12):1125-1133
pubmed: 32989305
Neurobiol Dis. 2003 Aug;13(3):177-90
pubmed: 12901832
J Cell Mol Med. 2016 Aug;20(8):1443-56
pubmed: 26990223
Biophys J. 2008 Jul;95(2):657-68
pubmed: 18375517
J Cell Sci. 2012 May 15;125(Pt 10):2416-27
pubmed: 22344258
Nat Chem Biol. 2010 Feb;6(2):140-7
pubmed: 20081829
Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11172-7
pubmed: 22745165
Sci Rep. 2019 Mar 26;9(1):5144
pubmed: 30914688
Sci Rep. 2016 Sep 13;6:32721
pubmed: 27619987
J Biol Chem. 2005 Apr 29;280(17):17294-300
pubmed: 15722360
Oncotarget. 2016 Jul 19;7(29):44991-45004
pubmed: 27391440
Biophys J. 2005 Apr;88(4):2706-13
pubmed: 15681641
ACS Chem Biol. 2019 Jul 19;14(7):1593-1600
pubmed: 31074957
Nat Commun. 2019 Jan 15;10(1):225
pubmed: 30644384
Eur Biophys J. 2006 Aug;35(6):523-31
pubmed: 16670880
Biochim Biophys Acta. 1995 Oct 4;1239(1):58-66
pubmed: 7548145
J Biol Chem. 2012 Jul 13;287(29):24765-73
pubmed: 22547072
Arch Neurol. 2008 Feb;65(2):184-9
pubmed: 18268186
FEBS J. 2011 Oct;278(20):3905-17
pubmed: 21722314
Neurobiol Aging. 2013 Sep;34(9):2100-9
pubmed: 23601807
Biochem J. 2004 Mar 1;378(Pt 2):281-92
pubmed: 14662007
Cell Calcium. 2018 May;71:65-74
pubmed: 29604965
Science. 2017 Dec 15;358(6369):1440-1443
pubmed: 29242346